A bacteriophage is a type of virus that infects bacteria. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. All bacteriophages ...

The team then synthesized a lysin from a bacteriophage, or virus that attacks bacteria, that infects S. hominis. During in vitro experiments, this lysin was found to target only S. hominis ...

Armata Pharmaceuticals, Inc.’s ARMP share price has dipped by 10.95%, which has investors questioning if this is right time ...

Melting a bacteriophage’s coat of proteins turns it into a tiny power plant, which could fire up the discovery of new bioengineered devices. Andrew is a freelance science writer and graduate student ...

Virulence of Yersinia has been studied in my laboratory since 1980 and the approach has been to use the tools of modern molecular biology and genetics to elucidate the selected aspects of it.

The Artstor website will be retired on Aug 1st. The Journal of Infectious Diseases Vol. 42, No. 4, Apr., 1928 The Twort-D'Herelle Phenomenon: A Critic... The Twort-D'Herelle Phenomenon: A Critical ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Hypharm GmbH has presented data regarding their recombinant chimeric bacteriophage endolysin HY-133 for the potential treatment of MRSA infection. HY-133 targets S. aureus and its design combines the ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) is expected to post its quarterly earnings results before the ...